Chemotherapy Drugs Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3200/- USD | Published Date: November 18, 2020 |

The global chemotherapy drugs market size is expected to grow at a significant CAGR of over 11% during the forecast period 2020 to 2027. The market growth is attributed to factors such as the increasing number of various cancer patients, growing chemotherapy treatments, and increasing demand for advance cancer drug across the globe. Furthermore, the growing expenditure on oncology medicine, increasing research and development activities, and rising health insurance are projected to boost the market growth over the forecast period. Moreover, rising public awareness and government initiatives are other factors to spur the market. However, the side effects of chemotherapy drugs are expected to hinder the market growth during the forecast period.

The demand for chemotherapy drugs is expected to witness significant growth due to the increasing number of cancer patients across the globe. According to WHO, 9.6 million deaths were calculated in 2018 due to cancer which is the second leading cause of death across the globe. In 2018, 18 million new cancer cases were found and among them, 2.09 million were recognized as breast cancer which is the most common cancer type. An increase in cancers such as lung, breast, leukemia, lymphoma, and prostate is projected to drive the chemotherapy drugs market globally.

Market Segment Insights:

The global chemotherapy drugs market is segmented on the basis of drug class, indication, route of administration, end-use, and geography. The segment is further classified into alkylating agents, mitotic inhibitors, antimetabolites, topoisomerase inhibitors, and antitumor antibiotics. The alkylating agent’s segment dominated the market in 2019 and anticipated to grow at the highest CAGR over the forecast period and projected to reach over USD 21 billion by 2025.

On the basis of indication, the global chemotherapy drugs market is divided into the lung, breast, prostate, skin, lymphoma, leukemia, and other cancers. The lung cancer segment held the largest market share in 2019 and expected to grow at the highest CAGR over the forecast period. By route of administration, the intravenous segment dominated the market in 2019 and the oral segment is accounted for the fastest-growing segment over the forecast period.

Global Chemotherapy Drugs Market Segmentation:

By Drug Class:

  • Alkylating Agents
  • Mitotic Inhibitors
  • Antimetabolites
  • Topoisomerase Inhibitors
  • Antitumor Antibiotic

By Indication:

  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Skin Cancer
  • Lymphoma
  • Leukemia
  • Others

By Route of Administration:

By End-Use:

  • Hospitals
  • Cancer Centers
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Global chemotherapy drugs market size and forecast were obtained by using “Bottom-up” and “Top-down” approaches. Extensive secondary research was conducted to understand the market insights and trends, followed by primary interviews to further validate the information sourced. The report provides both, qualitative and quantitative analyses of the market, the competitive landscape, and the preferred development strategies of key players which help to formulate competitive market strategies and make informed decisions.

Chemotherapy drugs Market research report presents the analysis of each segment from 2018 to 2027 considering 2019 as the base year for the research. Compounded Annual Growth Rate (CAGR) for each respective segments are calculated for the forecast period from 2020 to 2027.

Historical & Forecast Period:

  • 2018 – Historical Year for Chemotherapy Drugs Market
  • 2019 – Base Year for Chemotherapy Drugs Market
  • 2020-2027 – Forecast Period for Chemotherapy Drugs Market

Geographic Coverage:

Geographically, the chemotherapy drugs market report comprises dedicated sections centering on the regional market revenue and trends. The chemotherapy drugs market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific and Rest of the World (RoW). The RoW segment consists Latin America and the Middle East & Africa. The chemotherapy drugs market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance and others. chemotherapy drugs Market estimates have also been provided for the historical years 2018 & 2019 along with forecast for the period from 2020 – 2027.

Report Coverage:

  • Research Methodology
  • Research Scope
  • Executive Market Summary: Industry Snapshot
  • Industry Outlook
  • Critical Success Factors (CSFs) for the Market
  • Market Dynamics
  • Key Opportunities
  • Market Porters Five Force Analysis
  • Market Value Chain/Ecosystem Analysis
  • Market Attractive Investment Proposition
  • Market PESTEL Analysis
  • Market Positioning of Key Vendors
  • Market Segmentation Outlook
  • Regional Outlook
  • Company Profiles of Key Vendors

Market Competition Assessment:

Key players operating in the global Chemotherapy Drugs market are Sanofi, Boehringer Ingelheim GmbH, Novartis AG, Pfizer, Inc., and Merck & Co., Inc.

List of Key Companies:

  • Sanofi
  • Boehringer Ingelheim GmbH
  • Novartis AG
  • Pfizer, Inc.
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • AstraZeneca
  • Teva Pharmaceuticals Industries Ltd.
  • Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Celgene Corporation
  • Amgen, Inc.

Key Questions Answered by Chemotherapy Drugs Market Report:

  • Global Chemotherapy Drugs market forecasts from 2020-2027
  • Regional Chemotherapy Drugs market forecasts from 2020-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2020-2027 covering 15 major countries from the aforementioned regions
  • Chemotherapy Drugs submarket forecasts from 2020-2027 covering the market by drug class, by indication, by route of administration, by end-use, and geography
  • Various industry models such as SWOT analysis, Pestle Analysis, Porter’s Five Force model, Value Chain Analysis pertaining to Chemotherapy Drugs market
  • Analysis of the key factors driving and restraining the growth of the global, regional, and country-level Chemotherapy Drugs markets from 2020-2027
  • Competitive Landscape and market positioning of top 10 players operating in the Chemotherapy Drugs market

(Reports will be updated due to COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions
2. Executive Summary
2.1. Global Chemotherapy Drugs Market Portraiture
2.2. Global Chemotherapy Drugs Market, by Drug Class, 2019 (USD Mn)
2.3. Global Chemotherapy Drugs Market, by Indication, 2019 (USD Mn)
2.4. Global Chemotherapy Drugs Market, by Route of Administration, 2019 (USD Mn)
2.5. Global Chemotherapy Drugs Market, by End-Use, 2019 (USD Mn)
2.6. Global Chemotherapy Drugs Market, by Geography, 2019 (USD Mn)
3. Global Chemotherapy Drugs Market Analysis
3.1. Chemotherapy Drugs Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. Porter’s Five Force Analysis
3.6.1. Bargaining Power of Suppliers
3.6.2. Bargaining Power of Buyers
3.6.3. Threat of New Entrants
3.6.4. Threat of Substitutes
3.6.5. Degree of Competition
3.7. PESTEL Analysis
4. Global Chemotherapy Drugs Market By Drug Class, 2018 – 2027 (USD Mn)
4.1. Overview
4.2. Alkylating Agents
4.3. Mitotic Inhibitors
4.4. Antimetabolites
4.5. Topoisomerase Inhibitors
4.6. Antitumor Antibiotic
5. Global Chemotherapy Drugs Market By Indication, 2018 – 2027 (USD Mn)
5.1. Overview
5.2. Lung Cancer
5.3. Breast Cancer
5.4. Prostate Cancer
5.5. Skin Cancer
5.6. Lymphoma
5.7. Leukemia
5.8. Others
6. Global Chemotherapy Drugs Market By Route of Administration, 2018 – 2027 (USD Mn)
6.1. Overview
6.2. Intravenous
6.3. Oral
6.4. Topical
6.5. Others
7. Global Chemotherapy Drugs Market By End-Use, 2018 – 2027 (USD Mn)
7.1. Overview
7.2. Hospitals
7.3. Cancer Centers
7.4. Others
8. Global Chemotherapy Drugs Market, By Geography, 2018 – 2027 (USD Mn)
8.1. Introduction
8.2. North America
8.2.1. North America Chemotherapy Drugs Market by Country (2018-2027 USD Mn)
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. North America Chemotherapy Drugs Market by Drug Class (2018-2027 USD Mn)
8.2.3. North America Chemotherapy Drugs Market by Indication (2018-2027 USD Mn)
8.2.4. North America Chemotherapy Drugs Market by Route of Administration (2018-2027 USD Mn)
8.2.5. North America Chemotherapy Drugs Market by End-Use (2018-2027 USD Mn)
8.3. Europe
8.3.1. Europe Chemotherapy Drugs Market by Country (2018-2027 USD Mn)
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Rest of Europe
8.3.2. Europe Chemotherapy Drugs Market by Drug Class (2018-2027 USD Mn)
8.3.3. Europe Chemotherapy Drugs Market by Indication (2018-2027 USD Mn)
8.3.4. Europe Chemotherapy Drugs Market by Route of Administration (2018-2027 USD Mn)
8.3.5. Europe Chemotherapy Drugs Market by End-Use (2018-2027 USD Mn)
8.4. Asia Pacific
8.4.1. Asia Pacific Chemotherapy Drugs Market by Country (2018-2027 USD Mn)
8.4.1.1. China.
8.4.1.2. Japan
8.4.1.3. India
8.4.1.4. Australia
8.4.1.5. Rest of Asia Pacific
8.4.2. Asia Pacific Chemotherapy Drugs Market by Drug Class (2018-2027 USD Mn)
8.4.3. Asia Pacific Chemotherapy Drugs Market by Indication (2018-2027 USD Mn)
8.4.4. Asia Pacific Chemotherapy Drugs Market by Route of Administration (2018-2027 USD Mn)
8.4.5. Asia Pacific Chemotherapy Drugs Market by End-Use (2018-2027 USD Mn)
8.5. Latin America (LATAM)
8.5.1. Latin America Chemotherapy Drugs Market by Country (2018-2027 USD Mn)
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Chemotherapy Drugs Market by Drug Class (2018-2027 USD Mn)
8.5.3. Latin America Chemotherapy Drugs Market by Indication (2018-2027 USD Mn)
8.5.4. Latin America Chemotherapy Drugs Market by Route of Administration (2018-2027 USD Mn)
8.5.5. Latin America Chemotherapy Drugs Market by End-Use (2018-2027 USD Mn)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Chemotherapy Drugs Market, by Country (2018-2027 USD Mn)
8.6.1.1. South Africa
8.6.1.2. Rest of South Africa
8.6.2. MEA Chemotherapy Drugs Market by Drug Class (2018-2027 USD Mn)
8.6.3. MEA Chemotherapy Drugs Market by Indication (2018-2027 USD Mn)
8.6.4. MEA Chemotherapy Drugs Market by Route of Administration (2018-2027 USD Mn)
8.6.5. MEA Chemotherapy Drugs Market by End-Use (2018-2027 USD Mn)
9. Company Profiles
9.1. Sanofi
9.1.1. Business Description
9.1.2. Financial Health and Budget Allocation
9.1.3. Product Positions/Portfolio
9.1.4. News Coverage
9.2. Boehringer Ingelheim GmbH
9.3. Novartis AG
9.4. Pfizer, Inc.
9.5. Eli Lilly and Company
9.6. Bristol-Myers Squibb Company
9.7. GlaxoSmithKline Plc
9.8. AstraZeneca
9.9. Teva Pharmaceuticals Industries Ltd.
9.10. F. Hoffmann-La Roche Ltd
Fill the given form to inquiry before buying for Chemotherapy Drugs Market Report

Your Designtaion (required):

Select License Type
$3200/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client base has an annual subscription membership
  • 24x7 availability we are always there when you need us
  • 100,000+ data points in our comprehensive database
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report
For Any Assitance
Call Us: +919893685690
Contact Person: Mr. Vijendra Singh
Contact Email: sales@researchcorridor.com